Inclusion Criteria:  Must have participated in MAESTRO-NAFLD-1, completed the Week 52 visit, and completed the Week 56 visit within 90 days of the Extension Day 1 visit, and are willing to participate in the Extension study and provide written informed consent.  Must provide written informed consent for MAESTRO-NAFLD-OLE and must have screened and met all eligibility requirements for MAESTRO-NASH within 90 days of the Extension Day 1 visit for MAESTRO-NAFLD-OLE and have a liver biopsy that is ineligible for MAESTRO-NASH within 6 months of the Extension Day 1 visit. Eligible liver biopsy for MAESTRO-NAFLD-OLE must have one of the following results:  NAS = 3, steatosis 1, ballooning 1, inflammation 1 with F2 or F3 NAS = 3, ballooning 0 with F2 or F3 NAS ≥ 4, at least 1 in all NAS components, F1A or F1C, PRO-C3 ≤ 14 (NASH, but ineligible for MAESTRO-NASH)  Exclusion Criteria:  A history of significant alcohol consumption for a period of more than 3 consecutive months within 1 year prior to Extension Day 1. Diagnosis of hepatocellular carcinoma or other carcinomas that may prevent participation in the Extension study. Chronic liver diseases Has an active autoimmune disease Any other condition which, in the opinion of the Investigator, would impede compliance, hinder completion of the study, compromise the well-being of the patient, or interfere with the study outcomes.